BERLIN—Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared in vials of COVID-19 vaccine boosters retooled to target the Omicron variant of the coronavirus. Swissmedic said it had been informed by vaccination centers of the appearance of bubbles during the preparation of the updated vaccine from…
Swissmedic Approves Roche’s Ronapreve to Treat COVID-19 Patients
December 27, 2021
admin
Business & EconomyCCP VirusCompaniesCOVID-19EuropeHealth NewsPUBLIC HEALTH INFORMATIONRocheRonapreveSwissmedicWorld
0 Comment
ZURICH—Swiss drugs regulator Swissmedic said on Monday it approved Ronapreve, an antibody treatment jointly developed by Roche and Regeneron, to treat COVID-19 patients. “In this procedure, no data on efficacy against the Omicron variant were submitted,” Swissmedic said in a statement. The antibody treatment was already authorized for prescription in Switzerland under COVID-19 Ordinance 3…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta